Syros Pharmaceuticals, Inc. (SYRS) Stock Rising in Aftermarket, Here’s why.
Maria Masood
February 3, 2022
Syros Pharmaceuticals, Inc. (SYRS) is a major developer of therapeutics for oncology and monogenic diseases. The company’s pipeline candidate includes tamibarotene tried for treating myelodysplastic